The Goldman Sachs Group, Inc. - Net Worth and Insider Trading
The Goldman Sachs Group, Inc. Net Worth
The estimated net worth of The Goldman Sachs Group, Inc. is at least $144 Million dollars as of 2024-09-22. The Goldman Sachs Group, Inc. is the 2201 Interest of corporation controlled by you of CanSino Biologics Inc and owns about 6,775,478 shares of CanSino Biologics Inc (HKSE:06185) stock worth over $144 Million. Details can be seen in The Goldman Sachs Group, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that The Goldman Sachs Group, Inc. has not made any transactions after 2022-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, The Goldman Sachs Group, Inc. owns 1 companies in total, including CanSino Biologics Inc (HKSE:06185) .
Click here to see the complete history of The Goldman Sachs Group, Inc.’s form 4 insider trades.
Insider Ownership Summary of The Goldman Sachs Group, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2022-11-30 | 2201 Interest of corporation controlled by you |
The Goldman Sachs Group, Inc. Latest Holdings Summary
The Goldman Sachs Group, Inc. currently owns a total of 1 stock. The Goldman Sachs Group, Inc. owns 6,775,478 shares of CanSino Biologics Inc (HKSE:06185) as of November 30, 2022, with a value of $144 Million.
Latest Holdings of The Goldman Sachs Group, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2022-11-30 | 6,775,478 | 21.25 | 143,978,908 |
Holding Weightings of The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, The Goldman Sachs Group, Inc. has made a total of 2 transactions in CanSino Biologics Inc (HKSE:06185) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CanSino Biologics Inc is the acquisition of 627,000 shares on November 30, 2022, which cost The Goldman Sachs Group, Inc. around $62 Million.
Insider Trading History of The Goldman Sachs Group, Inc.
- 1
The Goldman Sachs Group, Inc. Trading Performance
GuruFocus tracks the stock performance after each of The Goldman Sachs Group, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by The Goldman Sachs Group, Inc. is -38.56%. GuruFocus also compares The Goldman Sachs Group, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by The Goldman Sachs Group, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how The Goldman Sachs Group, Inc.'s insider trading performs compared to the benchmark.
Performance of The Goldman Sachs Group, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -32.88 | | | | | |
| Relative Return to S&P 500(%) | -26.98 | | | | | |
The Goldman Sachs Group, Inc. Ownership Network
The Goldman Sachs Group, Inc. Owned Company Details
What does CanSino Biologics Inc do?
Who are the key executives at CanSino Biologics Inc?
The Goldman Sachs Group, Inc. is the 2201 Interest of corporation controlled by you of CanSino Biologics Inc. Other key executives at CanSino Biologics Inc include 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. , Jpmorgan Chase & Co. , and Citigroup Inc. .
CanSino Biologics Inc (HKSE:06185) Insider Trades Summary
Over the past 18 months, The Goldman Sachs Group, Inc. made no insider transaction in CanSino Biologics Inc (HKSE:06185). Other recent insider transactions involving CanSino Biologics Inc (HKSE:06185) include a net purchase of 146,461 shares made by Jpmorgan Chase & Co. , and a net sale of 8,998,500 shares made by The Capital Group Companies, Inc. .
In summary, during the past 3 months, insiders sold 0 shares of CanSino Biologics Inc (HKSE:06185) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,782,500 shares of CanSino Biologics Inc (HKSE:06185) were sold and 930,461 shares were bought by its insiders, resulting in a net sale of 8,852,039 shares.
CanSino Biologics Inc (HKSE:06185)'s detailed insider trading history can be found in Insider Trading Tracker table.
CanSino Biologics Inc Insider Transactions
The Goldman Sachs Group, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for The Goldman Sachs Group, Inc.. Currently GuruFocus does not have mailing address information for The Goldman Sachs Group, Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
